voriconazole	methadone	1	1	true	positive	Voriconazole    Repeat dose administration of oral voriconazole (400mg Q12h for 1 day, then 200mg Q12h for 4 days) increased the Cmax and AUC of (R)-methadone by 31% and 47%, respectively, in subjects receiving a methadone maintenance dose (30 to 100 mg QD).  		121243	6813	C102790	D008691
voriconazole	methadone	1	1	true	positive	Voriconazole    Repeat dose administration of oral voriconazole (400mg Q12h for 1 day, then 200mg Q12h for 4 days) increased the Cmax and AUC of (R)-methadone by 31% and 47%, respectively, in subjects receiving a methadone maintenance dose (30 to 100 mg QD).  		121243	6813	C102790	D008691
voriconazole	methadone	1	2	true	positive	Voriconazole    Repeat dose administration of oral voriconazole (400mg Q12h for 1 day, then 200mg Q12h for 4 days) increased the Cmax and AUC of (R)-methadone by 31% and 47%, respectively, in subjects receiving a methadone maintenance dose (30 to 100 mg QD).  The Cmax and AUC of (S)-methadone increased by 65% and 103%, respectively.  		121243	6813	C102790	D008691
voriconazole	methadone	1	2	true	positive	Voriconazole    Repeat dose administration of oral voriconazole (400mg Q12h for 1 day, then 200mg Q12h for 4 days) increased the Cmax and AUC of (R)-methadone by 31% and 47%, respectively, in subjects receiving a methadone maintenance dose (30 to 100 mg QD).  The Cmax and AUC of (S)-methadone increased by 65% and 103%, respectively.  		121243	6813	C102790	D008691
voriconazole	methadone	1	3	true	positive	Voriconazole    Repeat dose administration of oral voriconazole (400mg Q12h for 1 day, then 200mg Q12h for 4 days) increased the Cmax and AUC of (R)-methadone by 31% and 47%, respectively, in subjects receiving a methadone maintenance dose (30 to 100 mg QD).  The Cmax and AUC of (S)-methadone increased by 65% and 103%, respectively.  Increased plasma concentrations of methadone have been associated with toxicity including QT prolongation.  		121243	6813	C102790	D008691
voriconazole	methadone	1	3	true	positive	Voriconazole    Repeat dose administration of oral voriconazole (400mg Q12h for 1 day, then 200mg Q12h for 4 days) increased the Cmax and AUC of (R)-methadone by 31% and 47%, respectively, in subjects receiving a methadone maintenance dose (30 to 100 mg QD).  The Cmax and AUC of (S)-methadone increased by 65% and 103%, respectively.  Increased plasma concentrations of methadone have been associated with toxicity including QT prolongation.  		121243	6813	C102790	D008691
voriconazole	Voriconazole	1	1	true	positive	Voriconazole    Repeat dose administration of oral voriconazole (400mg Q12h for 1 day, then 200mg Q12h for 4 days) increased the Cmax and AUC of (R)-methadone by 31% and 47%, respectively, in subjects receiving a methadone maintenance dose (30 to 100 mg QD).  		C102790	121243
methadone	Voriconazole	1	1	true	positive	Voriconazole    Repeat dose administration of oral voriconazole (400mg Q12h for 1 day, then 200mg Q12h for 4 days) increased the Cmax and AUC of (R)-methadone by 31% and 47%, respectively, in subjects receiving a methadone maintenance dose (30 to 100 mg QD).  		6813	121243	D008691	121243
methadone	Voriconazole	1	1	true	positive	Voriconazole    Repeat dose administration of oral voriconazole (400mg Q12h for 1 day, then 200mg Q12h for 4 days) increased the Cmax and AUC of (R)-methadone by 31% and 47%, respectively, in subjects receiving a methadone maintenance dose (30 to 100 mg QD).  		6813	121243	D008691	121243
methadone	Voriconazole	2	1	true	positive	Voriconazole    Repeat dose administration of oral voriconazole (400mg Q12h for 1 day, then 200mg Q12h for 4 days) increased the Cmax and AUC of (R)-methadone by 31% and 47%, respectively, in subjects receiving a methadone maintenance dose (30 to 100 mg QD).  The Cmax and AUC of (S)-methadone increased by 65% and 103%, respectively.  		6813	121243	D008691	121243
methadone	Voriconazole	2	1	true	positive	Voriconazole    Repeat dose administration of oral voriconazole (400mg Q12h for 1 day, then 200mg Q12h for 4 days) increased the Cmax and AUC of (R)-methadone by 31% and 47%, respectively, in subjects receiving a methadone maintenance dose (30 to 100 mg QD).  The Cmax and AUC of (S)-methadone increased by 65% and 103%, respectively.  		6813	121243	D008691	121243
methadone	Voriconazole	3	1	true	positive	Voriconazole    Repeat dose administration of oral voriconazole (400mg Q12h for 1 day, then 200mg Q12h for 4 days) increased the Cmax and AUC of (R)-methadone by 31% and 47%, respectively, in subjects receiving a methadone maintenance dose (30 to 100 mg QD).  The Cmax and AUC of (S)-methadone increased by 65% and 103%, respectively.  Increased plasma concentrations of methadone have been associated with toxicity including QT prolongation.  		6813	121243	D008691	121243
methadone	Voriconazole	3	1	true	positive	Voriconazole    Repeat dose administration of oral voriconazole (400mg Q12h for 1 day, then 200mg Q12h for 4 days) increased the Cmax and AUC of (R)-methadone by 31% and 47%, respectively, in subjects receiving a methadone maintenance dose (30 to 100 mg QD).  The Cmax and AUC of (S)-methadone increased by 65% and 103%, respectively.  Increased plasma concentrations of methadone have been associated with toxicity including QT prolongation.  		6813	121243	D008691	121243
